(3-chlorophenyl)-[2-[[4-(3,4,5-trimethoxybenzoyl)piperazin-1-yl]methyl]morpholin-4-yl]methanone
C26H32ClN3O6 — CID 42861839
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3-chlorophenyl)-[2-[[4-(3,4,5-trimethoxybenzoyl)piperazin-1-yl]methyl]morpholin-4-yl]methanone
(3-chlorophenyl)-[2-[[4-(3,4,5-trimethoxybenzoyl)piperazin-1-yl]methyl]morpholin-4-yl]methanone (PubChem CID 42861839) has the molecular formula C26H32ClN3O6 and a molecular weight of 518.01 g/mol. Its IUPAC name is (3-chlorophenyl)-[2-[[4-(3,4,5-trimethoxybenzoyl)piperazin-1-yl]methyl]morpholin-4-yl]methanone.
Molecular Properties
| Compound Name | (3-chlorophenyl)-[2-[[4-(3,4,5-trimethoxybenzoyl)piperazin-1-yl]methyl]morpholin-4-yl]methanone |
|---|---|
| PubChem CID | 42861839 |
| Molecular Formula | C26H32ClN3O6 |
| Molecular Weight | 518.01 g/mol |
| Exact Mass | 517.20 |
| IUPAC Name | (3-chlorophenyl)-[2-[[4-(3,4,5-trimethoxybenzoyl)piperazin-1-yl]methyl]morpholin-4-yl]methanone |
| SMILES | COc1cc(C(=O)N2CCN(CC3CN(C(=O)c4cccc(Cl)c4)CCO3)CC2)cc(OC)c1OC |
| InChI | InChI=1S/C26H32ClN3O6/c1-33-22-14-19(15-23(34-2)24(22)35-3)26(32)29-9-7-28(8-10-29)16-21-17-30(11-12-36-21)25(31)18-5-4-6-20(27)13-18/h4-6,13-15,21H,7-12,16-17H2,1-3H3 |
| InChIKey | QANPWBKPPKXQHH-UHFFFAOYSA-N |
| XLogP | 2.66 |
| TPSA | 80.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.01 |
| LogP ≤ 5 | 2.66 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 42861839 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.